ERBB2 and breast cancer: Non-T4 breast cancer patient cases were observed to have an association with HER2+ status and poor OS on univariate analysis (hazards ratio = 1.19 vs. HER2-, 95% CI = 1.12 to 1.27), which was borderline nonsignificant on multivariate analysis.